Lloyd Mitchell Segal
Biotechnology and healthcare leader, advisor and investor.
Montreal, Quebec
Skills
Education
- HB
- BU
- MC
Work Experience
2020
Board Member
2020
2016 - 2025
President & Chief Executive Officer
2016 - 2025
Repare is a clinical-stage biotechnology company. Our mission is to be the leading precision oncology company delivering Synthetic Lethality/Genome Instability medicines that meaningfully improve the lives of cancer patients.
2006 - 2024
Member, Board of Directors, GBC American Fund
2006 - 2024
2016 - 2020
Entrepreneur in Residence
2016 - 2020
Versant Ventures is a leading San Francisco-based healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great healthcare companies. At Versant my focus was on leading the formation and development of new portfolio companies.
2017 - 2018
Chairman Of The Board Of Directors
2017 - 2018
MedReleaf (TSX:LEAF) was acquired in July, 2018, by Aurora Cannabis for US$2.5 billion to create the largest global cannabis producer.
2014 - 2018
Chairman
2014 - 2018
2010 - 2016
Managing Partner
2010 - 2016
Private equity fund investing in healthcare.
2014 - 2016
Member of the Board of Directors
2014 - 2016
Canada's Venture Capital and Private Equity National Association
2007 - 2014
Member, Board of Directors
2007 - 2014
2007 - 2013
Chairman of the Board of Directors
2010 - 2013
Chief Executive Officer
2007 - 2010